Hussein Kanji

Partner at Hoxton Ventures

Speaker

Hussein is a partner at Hoxton Ventures. He currently represents Hoxton on the boards of Baseimmune, BeyondRisk, Biocortex, Biotx, DruidAI, Finesse, Fy!, Giraffe360, Kbox, Kitt, Luminary, Peptone, PillSorted, Raptor Supplies, Really Clever, Rensair, Replai, Replan, Skin Analytics, TourRadar and XYZ Reality, and serves as a board observer on Behavox, Karakuri, Panakeia and Vidya Health. He previously served on the boards of Babylon Health (NYSE:BBLN), bd4travel (acquired by Dnata), Campanja (acquired by 24/7 Media), Darktrace (LSE:DARK), Deliveroo (LSE:ROO), SOCOS (acquired by Sophos) and Yieldify (acquired by Publicis).

Hussein serves on the board of Tech Nation, a UK quasi non-governmental organization, and UCLB, the commercialization company of UCL. He also sits on the advisory board of GTO Partners, a tech mid-market buyout firm, and Landscape, a venture capital review site. In a personal capacity, he is an angel investor in Apex:E3, Builder.ai, Callaly, GoCardless, Mellizyme, MyGlamm, Reachdesk and Signpost.

While forming Hoxton, he helped Eros STX Global develop ErosNow, an online streaming video platform for Bollywood. Prior to Hoxton, Hussein was an associate with Accel Partners. He joined Accel from Microsoft Corporation. Earlier in his career, he worked with three startups, Safe-View (acquired by L-3), Radiance Technologies (acquired by Comcast) and Studio Verso (acquired by KPMG).

Hussein holds an MBA from London Business School and did his undergraduate studies in Symbolic Systems at Stanford University.

He stubbornly refuses to swear allegiance to a monarch and remains a proud American.